Assessing the Risk of Vaccine-derived Outbreaks After Reintroduction of Oral Poliovirus Vaccine in Postcessation Settings

被引:8
作者
Fu, Rui [1 ]
Altamirano, Jonathan [2 ]
Sarnquist, Clea C. [2 ]
Maldonado, Yvonne A. [2 ]
Andrews, Jason R. [3 ]
机构
[1] Stanford Univ, Dept Management Sci & Engn, Stanford, CA 94305 USA
[2] Stanford Univ, Div Pediat Infect Dis, Sch Med, Stanford, CA 94305 USA
[3] Stanford Univ, Div Infect Dis & Geog Med, Sch Med, Stanford, CA 94305 USA
基金
比尔及梅琳达.盖茨基金会;
关键词
infectious diseases; oral polio vaccine; global OPV cessation; circulating vaccine-derived poliovirus; TRANSMISSION; LIVE; POLIOMYELITIS; POPULATION; CESSATION; ANTIBODY; IMMUNITY; CHILDREN; WILD;
D O I
10.1093/cid/ciy605
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. The Polio Eradication and Endgame Strategic Plan 2013-2018 calls for the gradual withdrawal of oral poliovirus vaccine (OPV) from routine immunization. We aimed to quantify the transmission potential of Sabin strains from OPV when it is reintroduced, accidentally or deliberately, in a community vaccinated with inactivated poliovirus vaccine alone. Methods. We built an individual-based stochastic epidemiological model that allows independent spread of 3 Sabin serotypes and differential transmission rates within versus between households. Model parameters were estimated by fitting to data from a prospective cohort in Mexico. We calculated the effective reproductive number for the Mexico cohort and simulated scenarios of Sabin strain resurgence under postcessation conditions, projecting the risk of prolonged circulation, which could lead to circulating vaccine-derived poliovirus (cVDPV). Results. The estimated effective reproductive number for naturally infected individuals was about 1 for Sabin 2 and Sabin 3 (OPV2 and OPV3) in a postcessation setting. Most transmission events occurred between households. We estimated the probability of circulation for >9 months to be (1) << 1% for all 3 serotypes when 90% of children <5 years of age were vaccinated in a hypothetical outbreak control campaign; (2) 45% and 24% for Sabin 2 and Sabin 3, respectively, when vaccine coverage dropped to 10%; (3) 37% and 8% for Sabin 2 and Sabin 3, respectively, when a single active shedder appeared in a community. Conclusions. Critical factors determining the risk of cVDPV emergence are the scale at which OPV is reintroduced and the between-household transmission rate for poliovirus, with intermediate values posing the greatest risk.
引用
收藏
页码:S26 / S34
页数:9
相关论文
共 26 条
[1]  
[Anonymous], 2017, GLOB POL ER IN ANN R
[2]   Unimmunized gypsy populations and implications for the eradication of poliomyelitis in Europe [J].
Aylward, RB ;
Porta, D ;
Fiore, L ;
Ridolfi, B ;
Chierchini, P ;
Forastiere, F .
JOURNAL OF INFECTIOUS DISEASES, 1997, 175 :S86-S88
[3]   Complexity in Mathematical Models of Public Health Policies: A Guide for Consumers of Models [J].
Basu, Sanjay ;
Andrews, Jason .
PLOS MEDICINE, 2013, 10 (10)
[4]   The role of older children and adults in wild poliovirus transmission [J].
Blake, Isobel M. ;
Martin, Rebecca ;
Goel, Ajay ;
Khetsuriani, Nino ;
Everts, Johannes ;
Wolff, Christopher ;
Wassilak, Steven ;
Aylward, R. Bruce ;
Grassly, Nicholas C. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2014, 111 (29) :10604-10609
[5]   Vaccine-Derived Polioviruses [J].
Burns, Cara C. ;
Diop, Ousmane M. ;
Sutter, Roland W. ;
Kew, Olen M. .
JOURNAL OF INFECTIOUS DISEASES, 2014, 210 :S283-S293
[6]   Seroprevalence of antibody against poliovirus in inner-city preschool children - Implications for vaccination policy in the United States [J].
Chen, RT ;
Hausinger, S ;
Dajani, AS ;
Hanfling, M ;
Baughman, AL ;
Pallansch, MA ;
Patriarca, PA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 275 (21) :1639-1645
[7]   EVOLUTION OF POLIOVIRUS SINCE INTRODUCTION OF ATTENUATED VACCINE [J].
COSSART, YE .
BRITISH MEDICAL JOURNAL, 1977, 1 (6077) :1621-1623
[8]  
DROZDOV SG, 1961, ACTA VIROL, V5, P210
[9]   Assessing the stability of polio eradication after the withdrawal of oral polio vaccine [J].
Famulare, Michael ;
Selinger, Christian ;
McCarthy, Kevin A. ;
Eckhoff, Philip A. ;
Chabot-Couture, Guillaume .
PLOS BIOLOGY, 2018, 16 (04)
[10]   Cessation of Trivalent Oral Poliovirus Vaccine and Introduction of Inactivated Poliovirus Vaccine - Worldwide, 2016 [J].
Hampton, Lee M. ;
Farrell, Margaret ;
Ramirez-Gonzalez, Alejandro ;
Menning, Lisa ;
Shendale, Stephanie ;
Lewis, Ian ;
Rubin, Jennifer ;
Garon, Julie ;
Harris, Jennifer ;
Hyde, Terri ;
Wassilak, Steven ;
Patel, Manish ;
Nandy, Robin ;
Chang-Blanc, Diana .
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2016, 65 (35) :934-938